DIO Corporation (KOSDAQ:039840)
10,270
+520 (5.33%)
Oct 12, 2026, 3:30 PM KST
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 131.52 billion as of October 12, 2026. It is the 25,468th most valuable company in the world and the 1,128th biggest in South Korea. Its market cap has decreased by 45.28% in one year.
Market Cap
131.52B
Enterprise Value
168.99B
Revenue
174.45B
Global Rank
Country Rank
#1,128 South Korea
PE Ratio
6.71
ChartMarket Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 131.52B, an increase of 417.37%. That is a compound annual growth rate of 6.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 131.52B | -41.84% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 56.37T |
| Celltrion | 41.03T |
| ALTEOGEN | 16.78T |
| Samsung Epis Holdings | 8.46T |
| Genexine | 132.12B |
| Macrogen | 132.05B |
| Dongbang Medical | 131.88B |
| Shinhung | 131.57B |